Unprecedented $10 million Federal Grant will boost the Valley

Translate to Spanish or other 102 languages!

methodist

- Advertisement -

Investment by Methodist Healthcare Ministries of South Texas, Inc. to stimulate improvements in behavioral health and chronic disease

Mega Doctor News

San Antonio, Texas Methodist Healthcare Ministries of south Texas, Inc., the largest private, faith-based funding source for healthcare services in South Texas, will announce during a special press conference in McAllen, Texas a major investment in the Rio Grande Valley thanks to an unprecedented federal grant.

- Advertisement -

The Social Innovation Fund (SIF), a key White House initiative and program of the Corporation for National and Community Service (CNCS), awarded $10 million in investments to MHM—the first-award from the SIF to a faith-based organization—to support its ‘Sí Texas: Social Innovation for a Healthy South Texas’ Project.

The objective of the Sí Texas Project is to stimulate improvements in behavioral health and chronic disease in South Texas, and to highlight integrated behavioral health models that are effectively improving health outcomes in communities with high rates of poverty, depression, diabetes, obesity and associated risk factors. The Sí Texas Project will target 12 counties that span the U.S.-Mexico border in South Texas—including Cameron, Hidalgo, Starr and Willacy counties in the Rio Grande Valley—and include grants made available to local agencies ranging from $250,000 to $2 million through an open, competitive application process.

Executive Team

Executive Team

Our team is dedicated to our mission of “Serving Humanity to Honor God.” Each team member brings the expertise, judgment, leadership and diversity of thought and experience required to make responsible decisions for all of our stakeholders.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

STHS Behavioral Marks Suicide Prevention Month with Community Chalk Event

Every 11 minutes, someone in the United States dies by suicide, according to the Centers for Disease Control and Prevention (CDC), making it one of the nation's leading causes of death.

Moderna and Merck Report Positive Phase 3 Results for Personalized Cancer Therapy

Moderna and Merck have reached a major clinical milestone after their investigational individualized cancer therapy, combined with Merck’s Keytruda, produced positive results in a Phase 3 study involving patients with high-risk melanoma.
- Advertisement -